Bajpai et al. showed that MM cells surviving glutamine deprivation, will upregulate BIM expression and promote BIM’s binding to BCL-2, rendering the MM cells more sensitive to venetoclax. The gene discussed is BCL2; the disease is Miyoshi myopathy.